Oncofocus TeamApr 101 minCAR-TRapid CAR-T Platforms: A Top-level AnalysisCAR-T therapy has dramatically changed the course of cancer management over the past few years. However, despite this impact, one of the...
Oncofocus TeamJan 111 minCAR-TTargeting the PD-1/PD-L1 immunosuppressive axis: CAR-T strategies under investigationPD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...
Oncofocus TeamApr 8, 20191 minCAR-TCAR-T Clinical Landscape ReportASCO 2019 Pre-conference Read A lot has happened in the CAR-T field in the past 10 months since our last conference report on this...
